http://www.xconomy.com/boston/2008/09/04/the-augmenix-question-can-amar-sawhney-do-it-again-with-latest-hydrogel-startup/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2008/09/04/the-augmenix-question-can-amar-sawhney-do-it-again-with-latest-hydrogel-startup/comment-page-1/#comment-40733 Alex Fri, 21 Nov 2008 15:54:15 +0000 http://www.xconomy.com/?p=4669#comment-40733 I was employed by Focal from 93-96 and would like to mention a few things regarding Amar Sahwney.First in no way should one confuse Amar with having anything to do with the mis-managed deal between Genzyme or the evntual "fall of Focal". Amar was an employee of Focal, young post doc graduate and the lead scientist for the company's technolgy. Thereby, he had nothing to do with or had an inputy in the business affairs or overall direction of the company obviously handled by an inept management team. We all lost something from Focal and its' demise but hopefully like Amar, you learn something from your experience,in this case what not to do, apply it and move on. It sounds like he is being blamed for the failure of a company he had no control of nor even a say in direction. Given his succesful track record since Focal, I would've preferred that he did. I was employed by Focal from 93-96 and would like to mention a few things regarding Amar Sahwney.First in no way should one confuse Amar with having anything to do with the mis-managed deal between Genzyme or the evntual “fall of Focal”. Amar was an employee of Focal, young post doc graduate and the lead scientist for the company’s technolgy. Thereby, he had nothing to do with or had an inputy in the business affairs or overall direction of the company obviously handled by an inept management team. We all lost something from Focal and its’ demise but hopefully like Amar, you learn something from your experience,in this case what not to do, apply it and move on. It sounds like he is being blamed for the failure of a company he had no control of nor even a say in direction. Given his succesful track record since Focal, I would’ve preferred that he did.

]]> http://www.xconomy.com/boston/2008/09/04/the-augmenix-question-can-amar-sawhney-do-it-again-with-latest-hydrogel-startup/comment-page-1/#comment-27693 Jim Fri, 05 Sep 2008 23:19:28 +0000 http://www.xconomy.com/?p=4669#comment-27693 Just remember, Focal investors like myself lost almost everything when Genzyme cut off further funding so they could by Focal for next to nothing in Genzyme Biosurgery stock and then took Genzyme Biosurgery shareholders through their forced sale of the company at a price less than the actual market value on the day of the sale. All this done after secret meetings where Genzyme's own people estimated the value at approximately 8 to 45 times the purchase price. All very legal and nice and tidy. Just remember, Focal investors like myself lost almost everything when Genzyme cut off further funding so they could by Focal for next to nothing in Genzyme Biosurgery stock and then took Genzyme Biosurgery shareholders through their forced sale of the company at a price less than the actual market value on the day of the sale. All this done after secret meetings where Genzyme’s own people estimated the value at approximately 8 to 45 times the purchase price. All very legal and nice and tidy.

]]>